Ludwig Cancer Research

Oncology & Cancer

Exploring the biology of 'double positive' T cells

The molecular markers CD4 and CD8—defining helper T cells and killer T cells, respectively—were once considered mutually exclusive. But "double positive" CD4+-CD8+ T cells have lately been discovered in people in various ...

Oncology & Cancer

A window into the changing tumor microenvironment

Researchers led by Ludwig Lausanne's Anoek Zomer, Davide Croci and Johanna Joyce described in a June publication in iScience their development of a multimodal imaging platform to explore, over extended periods, the changing ...

Oncology & Cancer

How intestinal cancer stem cells evade anti-angiogenic therapy

A team led by Ludwig Lausanne's Tatiana Petrova, Jeremiah Bernier-Latmani and alum Christoph Cisarovsky identified a novel mechanism by which stem cells in intestinal tumors generate new blood vessels and evade anti-angiogenic ...

Oncology & Cancer

New technique adds to the expanding suite of TAPS capabilities

In a new paper published in Nucleic Acids Research, a team led by Ludwig Oxford's Chunxiao Song reported a method for whole-genome long-read sequencing using TAPS (for Tet-assisted pyridine borane sequencing), the method ...

Oncology & Cancer

Automated assessment of pathology image quality

The analysis of tissue samples for cancer diagnosis and treatment is still largely done under the light microscope. But researchers are now developing technologies to speed up and ultimately improve the accuracy of such diagnostics ...

Oncology & Cancer

How cancer cells engineer macrophages to support cancer growth

A Ludwig Cancer Research study has identified a means by which cancer cells engineer the conversion of immune cells known as macrophages from destroyers of tumors to supporters of their growth and survival. The new research, ...

page 2 from 3